RECENT DEALS
RECENT DEALS
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
MERGERS AND ACQUISITIONS
Motient Corp. , an Illinois company that owns and operates a wireless communications network, bought 61 percent of McLean-based TerreStar Networks Inc. 's common stock. Total consideration for the transaction was $200 million. Deutsche Bank advised Motient Corp on the transaction.
Fiserv Inc. , a Wisconsin-based technology company serving the mortgage industry, agreed to buy the assets of the McLean-based eLending U.S. operations of Emergis Inc . Total consideration for the transaction was approximately $13.75 million.
McDonald Bradley Inc. , a McLean information technology company, agreed to acquire Herndon's
Infodata Systems Inc . for $5.88 million. BB&T Capital Markets advised McDonald on the transaction.
Science Applications International Corp. completed the acquisition of Object Sciences Corp. of Alexandria. Object Sciences Corporation provides an array of information technology solutions to the federal government. Terms of the transaction were undisclosed.
PRIVATE EQUITY
Deltek Systems Inc. , a private business software company in Herndon, said its controlling deLaski family sold 75 percent of the company to New Mountain
Capital of New York. An SEC filing by Deltek said the deal totaled $205 million. The deLaski family, led by chief executive Kenneth E. deLaski , retained 25 percent interest in the company.
RegeneRx Biopharmaceuticals Inc. , a Bethesda biotechnology company, sold $7.7 million of common stock and warrants to buy common stock to 23 investors, according to an SEC filing. RegeneRx will use the money for working capital. ThinkEquity
